Re: Corporate Welfare: was Re: RMS's note to am-info regarding software development models...

[James Love <love@cptech.org>]

The situation with pharmaceutical drugs is a colossal rip off.  

   Jamie    

Eric Bennett wrote:
> 
> James Love wrote:
> 
> > ..... Consider also the pharmaceutical industry.  Try, for example, to
> > name a single cancer drug that was not developed with public R&D
> > subsidies.    Jamie
> 
> But these research results are hardly analogous to GPLed software.  If
> they were, there would be a restriction that says: "If you use the
> results of publicly funded research as the basis for developing a drug,
> you must make the results of your research publicly available and usable
> by anyone under the same terms through which the previous results were
> made available to you."  Then the drug companies wouldn't be able to
> patent their drugs, and other companies could make generic drugs
> immediately.
> 
> The actual situation seems a lot closer to the style BSD license, where
> anybody can do whatever they want with the results of the research.
> 
> --
> Eric Bennett ( ericb@pobox.com ; http://www.pobox.com/~ericb )
> Department of Chemistry, Cornell University
> 377 S.T. Olin Chemistry Lab
> 
> Mr. Gates needs a memory upgrade.
> -Mitchell Pettit, Executive Director, ProComp

-- 
James Love, Consumer Project on Technology
P.O. Box 19367, Washington, DC 20036
202.387.8030; f 202.234.5176
http://www.cptech.org, mailto:love@cptech.org